Letter to the Editor. Puzzling posology: was the bevacizumab regimen in recurrent glioblastoma misreported?
- PMID: 29171803
- DOI: 10.3171/2017.5.JNS171208
Letter to the Editor. Puzzling posology: was the bevacizumab regimen in recurrent glioblastoma misreported?
Comment on
-
Bevacizumab and irinotecan therapy in glioblastoma multiforme: a series of 13 cases.J Neurosurg. 2008 Aug;109(2):268-72. doi: 10.3171/JNS/2008/109/8/0268. J Neurosurg. 2008. PMID: 18671639 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
